ARTICLE | Company News
Neurocrine resubmits Indiplon-MR NDA
May 27, 2005 12:33 AM UTC
NBIX resubmitted an NDA to FDA for Indiplon modified-release (MR) tablets to treat insomnia in adult and elderly patients. The NDA for Indiplon immediate-release (IR) capsules was resubmitted in April...